![Gintaras ZALESKIS - Research Associate - National Cancer Institute, Lithuania - Laboratory of Immunology Gintaras ZALESKIS - Research Associate - National Cancer Institute, Lithuania - Laboratory of Immunology](https://i1.rgstatic.net/ii/profile.image/988163933749248-1612608049148_Q512/Gintaras-Zaleskis.jpg)
Gintaras ZALESKIS - Research Associate - National Cancer Institute, Lithuania - Laboratory of Immunology
![Thymic anti‐tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF‐α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation - Ehrke - 1998 - International Journal Thymic anti‐tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF‐α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation - Ehrke - 1998 - International Journal](https://onlinelibrary.wiley.com/cms/asset/fd34d85b-39d1-4206-a27c-2c8213723fcf/ijc.v151.7.cover.jpg?trick=1660555104162)
Thymic anti‐tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF‐α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation - Ehrke - 1998 - International Journal
![Understanding Cancer: Evidence-based Misinformation About Supplements eBook : Zaleskis, Gintaras, Hudson, Bret, Miskinyte-Hudson, Ruta: Amazon.in: Kindle Store Understanding Cancer: Evidence-based Misinformation About Supplements eBook : Zaleskis, Gintaras, Hudson, Bret, Miskinyte-Hudson, Ruta: Amazon.in: Kindle Store](https://images-eu.ssl-images-amazon.com/images/I/41BQGTNOx5L._SX342_SY445_QL70_ML2_.jpg)
Understanding Cancer: Evidence-based Misinformation About Supplements eBook : Zaleskis, Gintaras, Hudson, Bret, Miskinyte-Hudson, Ruta: Amazon.in: Kindle Store
![Protective specific immunity induced by doxorubicin plus TNF‐α combination treatment of EL4 lymphoma–bearing C57BL/6 mice - Ehrke - 2000 - International Journal of Cancer - Wiley Online Library Protective specific immunity induced by doxorubicin plus TNF‐α combination treatment of EL4 lymphoma–bearing C57BL/6 mice - Ehrke - 2000 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a5cfc054-844f-4905-bb92-31f5bd71ee42/ijc.v151.8.cover.jpg?trick=1662517035745)
Protective specific immunity induced by doxorubicin plus TNF‐α combination treatment of EL4 lymphoma–bearing C57BL/6 mice - Ehrke - 2000 - International Journal of Cancer - Wiley Online Library
Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?
![JCM | Free Full-Text | Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients JCM | Free Full-Text | Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients](https://www.mdpi.com/jcm/jcm-10-03709/article_deploy/html/images/jcm-10-03709-g003.png)
JCM | Free Full-Text | Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
![Comparative Evaluation of Cellular Uptake of Free and Liposomal Doxorubicin Following Short Term Exposure | Anticancer Research Comparative Evaluation of Cellular Uptake of Free and Liposomal Doxorubicin Following Short Term Exposure | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/5/2363/F1.large.jpg)
Comparative Evaluation of Cellular Uptake of Free and Liposomal Doxorubicin Following Short Term Exposure | Anticancer Research
![Rokiskiosirena.lt - Imunologas Gintaras Zaleskis: esu visiškai tikras, kad kaukė - tai tik paklusnumo ženklas (video) Rokiskiosirena.lt - Imunologas Gintaras Zaleskis: esu visiškai tikras, kad kaukė - tai tik paklusnumo ženklas (video)](https://rokiskiosirena.lt/cache/images/0/a/b/2/c/0ab2c3567832432a1ef59b59a8591fc21675a3e7.png)
Rokiskiosirena.lt - Imunologas Gintaras Zaleskis: esu visiškai tikras, kad kaukė - tai tik paklusnumo ženklas (video)
![European Urology | Vol 82, Issue 4, Pages e95-e124, 339-448 (October 2022) | ScienceDirect.com by Elsevier European Urology | Vol 82, Issue 4, Pages e95-e124, 339-448 (October 2022) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S0302283822X00109-cov200h.gif)
European Urology | Vol 82, Issue 4, Pages e95-e124, 339-448 (October 2022) | ScienceDirect.com by Elsevier
![Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention](https://www.jcancer.org/v11/p6497/jcav11p6497g003.jpg)
Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention
![Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention](https://www.jcancer.org/v11/p6497/jcav11p6497g002.jpg)
Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention
![PDF) Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients PDF) Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients](https://i1.rgstatic.net/publication/354072461_Immunophenotype_Rearrangement_in_Response_to_Tumor_Excision_May_Be_Related_to_the_Risk_of_Biochemical_Recurrence_in_Prostate_Cancer_Patients/links/6123a92c1e95fe241aede661/largepreview.png)
PDF) Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
![JCM | Free Full-Text | Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients JCM | Free Full-Text | Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients](https://www.mdpi.com/jcm/jcm-10-03709/article_deploy/html/images/jcm-10-03709-g001.png)